文献速递脑血管病

年龄与基线NIHSS对急性大血管闭塞性卒中预后影响的比较

Comparing the Prognostic Impact of Age and Baseline National Institutes of Health Stroke Scale in Acute Stroke due to Large Vessel Occlusion.
PubMed 文献 · Stroke · 2021-07-08

基于HERMES协作组1750例急性大血管闭塞性卒中患者,分析年龄与基线NIHSS对90天良好预后影响的相对权重。NIHSS每增加1分对良好预后的影响约相当于年龄增加3岁,加权SPAN指数为3×NIHSS+年龄。血管内治疗在各加权SPAN亚组中均一致获益,需治疗人数5.3至8.7。

要点

  • NIHSS每增1分对良好预后的负面影响约相当于年龄增加3岁。
  • 加权SPAN指数(3×NIHSS+年龄)可用于综合评估预后风险。
  • 血管内治疗在各加权年龄/NIHSS亚组中均一致获益。

核心结论

  • NIHSS增加1分对90天良好预后(mRS 0-2)的影响约相当于年龄增加3岁。
  • 血管内治疗在所有加权年龄/NIHSS亚组中均显示获益。

研究设计与样本

  • 基于HERMES协作组的回顾性队列分析,纳入1750/1766例有年龄和NIHSS数据的急性大血管闭塞性卒中患者。
  • 采用校正逻辑回归模型,以90天mRS 0-2为主要结局,计算NIHSS与年龄的效应系数比值。

主要发现

  • 中位NIHSS为17(IQR 13-21),中位年龄为68岁(IQR 57-76)。
  • 682/1743例(39%)患者达到90天良好预后(mRS 0-2)。
  • NIHSS/年龄效应系数比为([-0.0032]/[-0.111])=3.4,取整为3,加权SPAN指数定义为(3×NIHSS)+年龄。
  • 按加权SPAN每增加3分划分亚组,血管内治疗效应估计一致倾向于获益,需治疗人数范围为5.3至8.7。

关键数值与推荐

  • 加权SPAN指数=3×NIHSS+年龄,用于比较NIHSS与年龄的相对预后影响。
  • 亚组分析按加权SPAN增量3分划分,评估血管内治疗效应变化。

临床怎么用

  • 临床可借助加权SPAN指数(3×NIHSS+年龄)综合评估急性大血管闭塞性卒中患者的预后风险。
  • 不应仅因年龄较大或NIHSS较高而否定血管内治疗,因各加权亚组均一致获益。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Little is known about the combined effect of age and National Institutes of Health Stroke Scale (NIHSS) in endovascular treatment (EVT) for acute ischemic stroke due to large vessel occlusion, and it is not clear how the effects of baseline age and NIHSS on outcome compare to each other. The previously described Stroke Prognostication Using Age and NIHSS (SPAN) index adds up NIHSS and age to a 1:1 combined prognostic index. We added a weighting factor to the NIHSS/age SPAN index to compare the relative prognostic impact of NIHSS and age and assessed EVT effect based on weighted age and NIHSS. METHODS: We performed adjusted logistic regression with good outcome (90-day modified Rankin Scale score 0–2) as primary outcome. From this model, the coefficients for NIHSS and age were obtained. The ratio between the NIHSS and age coefficients was calculated to determine a weighted SPAN index. We obtained adjusted effect size estimates for EVT in patient subgroups defined by weighted SPAN increments of 3, to evaluate potential changes in treatment effect. RESULTS: We included 1750/1766 patients from the HERMES collaboration (Highly Effective Reperfusion Using Multiple Endovascular Devices) with available age and NIHSS data. Median NIHSS was 17 (interquartile range, 13–21), and median age was 68 (interquartile range, 57–76). Good outcome was achieved by 682/1743 (39%) patients. The NIHSS/age effect coefficient ratio was ([−0.0032]/[−0.111])=3.4, which was rounded to 3, resulting in a weighted SPAN index defined as ([3×NIHSS]+age). Cumulative EVT effect size estimates across weighted SPAN subgroups consistently favored EVT, with a number needed to treat ranging from 5.3 to 8.7. CONCLUSIONS: The impact on chance of good outcome of a 1-point increase in NIHSS roughly corresponded to a 3-year increase in patient age. EVT was beneficial across all weighted age/NIHSS subgroups.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Ospel JM, Brown S, Kappelhof M, et al. Comparing the Prognostic Impact of Age and Baseline National Institutes of Health Stroke Scale in Acute Stroke due to Large Vessel Occlusion. Stroke. 2021. PMID: 34233465. doi:10.1161/STROKEAHA.120.032364

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。